Læknablaðið : fylgirit - 05.01.2015, Qupperneq 79

Læknablaðið : fylgirit - 05.01.2015, Qupperneq 79
X V I I V Í S I N D A R Á Ð S T E F N A H Í F Y L G I R I T 8 2 LÆKNAblaðið/Fylgirit 82 2015/101 79 sóra. Peptíðið LL-37 er mikilvæg vörn gegn sýkingum jafnt sem ræsingu ónæmiskerfisins, en hlutverk þess í ónæmiskerfi húðar er óljóst. Þekking á staðsetningu og niðurbroti LL-37 í húð sórasjúklinga getur því leitt til aukins skilnings á sjúkdómnum og hugsanlega nýrra meðferðarúrræða. Efniviður og aðferðir: Húðsýnum var safnað með húðsýnapenna frá einstaklingum með skellusóra fyrir og eftir 6 vikna meðferð á með- ferðarmiðstöð Bláa lónsins. Psoriasis Area Severity Index (PASI) var reiknaður fyrir og eftir meðferð og sýnin fryst í vaxi, skorin í örþunnar sneiðar og LL-37 lituð með flúrljómandi mótefni. Niðurstöður: Staðsetning litunar fylgir PASI-gildi í viðkomandi húð. Þannig sýna sneiðar sem fengnar voru frá húð með háu PASI-gildi, í upphafi meðferðar, LL-37 litun sem nær frá yfirborði hornhimnu niður í neðri frumulög epidermis (stratum spinosum). Í sýnum sem fengin eru frá húð með lágu PASI-gildi aftur á móti, sést LL-37 litun sem tak- markast við efstu lög epidermis, þ.e. rétt undir hornhimnunni (stratum granulosum og lucidum) eftir meðferð. Ályktanir: Stöðugleiki og staðsetning LL-37 í húð með háu PASI-skori kemur á óvart. Sérstaklega þar sem staðsetning ber saman við stað- setningu Cathepsin D, proteasa sem þekktur er fyrir að brjóta niður og óvirkja LL-37. Frekari rannsókna er því þörf til að athuga afvirkjun Cathepsin D og/eða verndun LL-37 í húðvökva einstaklinga með skellusóra. V 70 Vitamin D and major depressive disorder among elderly: AGES-Reykjavik Study Cindy Mari Imai1, Þórhallur Ingi Halldórsson1, Guðný Eiríksdóttir2, Tamara Harris3, Mary Frances Cotch4, Vilmundur Guðnason2,5, Ingibjörg Gunnarsdóttir1 1Unit for Nutrition Research, University of Iceland, Landspítali University Hospital, 2Icelandic Heart Association, 3Laboratory of Epidemiology, Demography, and Biometry, Intramural Research Program, National Institute on Agining, 4Division of Epidemiology and Clinical Applications, National Eye Institute, 5Faculty of Medicine, University of Iceland cmi1@hi.is Introduction: Research on the association between vitamin D and de- pressive symptoms is growing; however, investigations among comm- unity dwelling elderly are scarce. The aim was to determine whether vitamin D levels were associated with depression among elderly Icelanders with relatively high cod liver oil intake. Methods and data: Participants of the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study, age 66-96 years (n=5151), with serum 25-hydroxyvitamin D (25(OH)D) measures. Lifetime occurrence of major depressive disorder was assessed according to DSM-IV criteria. Frequency of cod liver oil intake was collected via food frequency ques- tionnaire. Vitamin D levels were categorized as deficient (<30 nmol/L), depleted (30-50 nmol/L) and adequate (>50 nmol/L). Logistic regression analyses were performed and adequate 25(OH)D levels served as the reference group. Results: Men who had deficient vs. adequate 25(OH)D levels were more likely to be depressed, odds ratio (OR) 2.12 (95% CI: 1.16, 3.88). Among women, a U-shaped trend was observed with corresponding OR 0.89 (95% CI: 0.57, 1.39) and 0.64 (0.42, 0.97), for deficient and depleted 25(OH)D levels, respectively. Adjustments for cod liver oil intake did not markedly change the OR. Conclusions: In this elderly cohort, low vitamin D status may be a predictor of depression among men, while the association appears more complex among women. With increasing life expectancy, the prevalence of depression may be on the rise and there is a need to better identify and prevent depression among individuals of advanced age. V 71 Flúorosa tanna og flúormagn í sýnum af drykkjarvatni í Tanzaníu Elísabet Ásta Bjarkadóttir, Lára Hólm Heimisdóttir, Unnur Flemming Jensen Tannlæknadeild Háskóla Íslands tannsar2015@gmail.com Inngangur: Flúor í drykkjarvatni getur annaðhvort komið frá náttúr- unnar hendi eða verið bætt í vatnið. Styrkur flúors sem kemur frá nátt- úrunni í drykkjarvatni er þekktur fyrir að vera hár á ákveðnum svæðum í Afríku, þá einkum Tansaníu. Markmið rannsóknarinnar var að sjá hvort væri samband milli flúorosu tanna í íbúum í Tansaníu og magn flúors í drykkjarvatni þeirra. Efniviður og aðferðir: Úrtakið voru 159 sjálfboðaliðar á aldrinum 5-87 ára frá Norðaustur-Tansaníu. Hver þátttakandi eða foreldri svaraði spurningalista og teknar voru klínískar ljósmyndir af tönnum. Vatnssýni voru tekin frá mismunandi svæðum í Norður-Tansaníu. Flúorosa tanna var mæld af stöðluðum rannsakendum og notaður var einfaldaður TF index ásamt ljósmyndunum. Styrkur flúors var mældur í 11 vatnssýnum með ICS 2000, Ion Chromatograph(Dionex). Niðurstöður: Breytingar sem líkjast flúorosu sáust á tönnum 124 ein- staklinga (78%). Þessar breytingar voru svo flokkaðar í mildar í 39,6% tilvika, miðlungs í 27% tilvika en alvarlegar (TF >7) í 11,3% tilvika. Flúormagn í drykkjarvatninu var breytilegt en sum þéttbýl svæði höfðu drykkjarvatn þar sem flúormagnið var 2,5 ppm en önnur minna þétt svæði höfðu flúormagn 0,1 – 0,6 ppm. Ályktanir: Flúorosa tanna er algeng á ákveðnum svæðum í Tansaníu. Flúorosan sem greind var ber saman við flúormagnið sem mælt var í drykkjarvatninu. Það er greinilegt að vekja þarf athygli á flúormagni í drykkjarvatni á ákveðnum svæðum í Afríku og áhrifum þess á tennur. V 72 Genetic lineages of invasive group B streptococcal infections among adults Iceland: 1978-2012 Erla Soffía Björnsdóttir1,2, Elisabete R. Ferreira Martins3, Helga Erlendsdóttir1, Gunnsteinn Haraldsson1, José Melo-Cristino4, Mário Ramirez3, Karl G. Kristinsson1 1Department of Microbiology, Landspítala University Hospital, 2Faculty of Medicine, University of Iceland, 3Molecular Microbiology and Infection Unit, Instituto de Medicina Molecular, 4Instituto de Microbiologia, Faculty of Medicine, University of Lisbon erlasoff@landspitali.is Introduction: We undertook the analysis of 134 group B streptococci (GBS) isolates recovered from cases of invasive infection in adults in Iceland, between 1978 and 2012 to document the prevalence of seroty- pes, genetic lineages and antimicrobial resistance patterns. Methods and data: All isolates were serotyped and assigned to clones according to their PFGE profiles and MLST-based sequence types. All isolates where also tested for antimicrobial susceptibility and presence of surface protein genes and pili islands was tested by PCR. Results: The isolates were grouped into 11 PFGE clusters. The most frequent serotype was Ia with 23% but serotypes V, III, Ib and II were 14-19%. Although serotype V was not the dominant serotype in Iceland, it was represented mainly by a single PFGE cluster defined by ST1/alp3, similarly to what has been described elsewhere. On the other hand, the more frequent serotype Ia isolates were distributed across several PFGE clusters and genetic lineages, mainly ST23/eps, but also ST24/ bca. The combination PI-1+PI-2a was found in 66% of all isolates. All isolates were susceptible to penicillin. The overall rate of erythromycin and clindamycin resistance was 6.0% and 9.0%, respectively, and an overrepresentation of erythromycin resistance was observed in serotype V/ST1/alp3 genetic lineage (p<0.05).
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158
Qupperneq 159
Qupperneq 160
Qupperneq 161
Qupperneq 162
Qupperneq 163
Qupperneq 164
Qupperneq 165
Qupperneq 166
Qupperneq 167
Qupperneq 168
Qupperneq 169
Qupperneq 170
Qupperneq 171
Qupperneq 172
Qupperneq 173

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.